Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common stock, $0.001 par value
-
Shares outstanding
-
63.2M
-
Number of holders
-
121
-
Total 13F shares, excl. options
-
35.5M
-
Shares change
-
+7.27M
-
Total reported value, excl. options
-
$895M
-
Value change
-
+$184M
-
Put/Call ratio
-
0.12
-
Number of buys
-
88
-
Number of sells
-
-36
-
Price
-
$25.19
Significant Holders of TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) as of Q1 2023
144 filings reported holding TMCI - TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value as of Q1 2023.
TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) has 121 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35.5M shares
of 63.2M outstanding shares and own 56.2% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (3.85M shares), ALLIANCEBERNSTEIN L.P. (3.22M shares), BlackRock Inc. (2.6M shares), PERCEPTIVE ADVISORS LLC (2.44M shares), NEXT CENTURY GROWTH INVESTORS LLC (1.54M shares), CIBC Private Wealth Group, LLC (1.41M shares), EMERALD ADVISERS, LLC (1.36M shares), EMERALD MUTUAL FUND ADVISERS TRUST (1.12M shares), LOOMIS SAYLES & CO L P (1.09M shares), and NORGES BANK (1.01M shares).
This table shows the top 121 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.